ANAB: AnaptysBio Inc Kompaniya qiymatining sof foydaga nisbati
Geopolitik beqarorlik va patent risklari AnaptysBio, Inc. (ANAB) uchun ta'minot zanjiri muammolarini keltirib chiqarmoqda. Emitentning P/E tarixi biznesni baholashdagi tarkibiy nomutanosibliklarni namoyish etadi, bunda 7.30 darajasi ushbu metrikaning joriy miqdorini aks ettiradi. Sog'liqni saqlash gigantlari bilan sinergiya yangi antitelalarni qidirishni tezlashtirmoqda, dermatitisga qarshi dori vositalarini tijoratlashtirishga tayyorgarliklar esa kompaniyaning ishlanmalarining yuqori tibbiy ahamiyatini tasdiqlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_ANAB_-_AnaptysBio-Inc._-_PE-Multiple "ANAB: AnaptysBio, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
AnaptysBio Corp (ANAB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati AnaptysBio, Inc.|ANAB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati AnaptysBio Inc.|ANAB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati AnaptysBio, Inc.|ANAB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz AnaptysBio|Tezkor likvidlik koeffitsiyenti anaptysbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
ANAB - Kompaniyaning sof foydasi|Sof foyda prognozi AnaptysBio, Inc.|ANAB - P/E multiplikatori|Forvard P/E multiplikatori AnaptysBio Inc|ANAB - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati AnaptysBio, Inc.|ANAB - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda AnaptysBio|ANAB - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi anaptysbio.com|ANAB - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi AnaptysBio, Inc.
Kompaniyaning har tomonlama tahlili:anaptysbio.com ANAB
AnaptysBio, Inc. immunologiya sohasidagi yuqori nufuzidan foydalangan holda, og'ir yallig'lanish jarayonlarini davolash uchun innovatsion antitanalarni ishlab chiqishga ixtisoslashgan. Kompaniyaning normallashtirilgan P/E ko'rsatkichini tahlil qilish joriy bozor kapitalizatsiyasini haqiqiy daromadlar bilan solishtirish imkonini beradi, foydaning har bir birligi qiymatini aniqlaydi va investorlarga emitentning biofarmatsevtika ishlanmalarining kelajakdagi salohiyati uchun to'langan premiumni baholashga yordam beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Narx-foyda multiplikatori PHAR|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Upstream Bio, Inc.|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|IMNM: Kapitalizatsiyaning sof foydaga nisbati|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KALV (kalvista.com)|SEPN: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pieris Pharma|Savara Corp (SVRA) - Narxning foydaga nisbati|RIGL - Biznesning o‘zini qoplash muddati|ATXS (Astria Therapeutics) - P/E multiplikatori|Narxning foydaga nisbati ENGN|P/E multiplikatori RAPT|Biznesning o‘zini qoplash muddati aerovatetx.com|Narxning foydaga nisbati Aclaris ACRS|Kyverna Therapeutics, Inc (KYTX) - Kapitalizatsiyaning foydaga nisbati|TLSA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CABA (cabalettabio.com)|VTYX: P/E multiplikatori|THTX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Avalo Therapeutics Inc.|Narx-foyda multiplikatori ELDN (Eledon Pharmaceuticals, Inc)|P/E multiplikatori AGEN|Narx-foyda koeffitsiyenti climbbio.com CLYM|Zura Bio - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati aTyr Pharma Inc (ATYR)|Adagene Corp - P/E multiplikatori|IMA - P/E multiplikatori|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda multiplikatori EQ|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|P/E multiplikatori Immunic Inc|P/E multiplikatori ATRA|Narxning foydaga nisbati IFRX (inflarx.de)|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET (Adicet Bio Inc.) - Kapitalizatsiyaning sof foydaga nisbati|Celularity Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|AKTX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTLB: P/E multiplikatori|BOLT - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|GRI Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND - Narxning foydaga nisbati|REVB (Revelation Biosciences Corp) - Narx-foyda multiplikatori|INDP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati scinai.com (SCNI)|CALI (CalciMedica Inc) - P/E multiplikatori|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|P/E multiplikatori iteostherapeutics.com ITOS|OCEA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TCBP|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
